PDCD1 and neoplasm: We further showed that inhibiting estrogen production in obese males resulted in the loss of anti–PD-1 efficacy, suggesting that beyond their known pro-tumor and tumor-suppressive properties, estrogens may have a determining role in the induction of the antitumor immune response.